Cilengitide in Treating Patients With Prostate Cancer
NCT00121238
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
16
Enrollment
NIH
Sponsor class
Conditions
Recurrent Prostate Cancer
Stage I Prostate Cancer
Stage IIA Prostate Cancer
Stage IIB Prostate Cancer
Stage III Prostate Cancer
Interventions
DRUG:
cilengitide
Sponsor
National Cancer Institute (NCI)